News and Press Releases

Turn.bio Announces Preliminary Results of a CAR-T Cell Study

Turn.bio Announces Preliminary Results of a CAR-T Cell Study

This company is working towards perfecting cellular reprogramming by Arkadi Mazin - Lifespan.io Turn.bio, a developer of mRNA-based cellular reprogramming technologies, has announced preliminary results from its current trial. The announcement was made by the...

read more
What will the $100 genome mean?

What will the $100 genome mean?

Sequencing the human #genome for $100 (or less) will undoubtedly open up new areas of research & improve human health- impacting #healthspan & #longevity. Newborn screening will predict chronic diseases. It will serve as a boon to underfunded diseases such as...

read more
Framework for 3D Bioprinting Plant Cells Developed

Framework for 3D Bioprinting Plant Cells Developed

By North Carolina State University - Technology Networks A new study from North Carolina State University shows a reproducible way of studying cellular communication among varied types of plant cells by “bioprinting” these cells via a 3D printer. Learning more about...

read more